Walter Rakowich Sells 1,152 Shares of Ventas (NYSE:VTR) Stock

Ventas, Inc. (NYSE:VTR) Director Walter Rakowich sold 1,152 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the sale, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This represents a 3.90% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ventas Trading Down 2.8%

Shares of NYSE:VTR opened at $87.47 on Friday. Ventas, Inc. has a 12-month low of $61.76 and a 12-month high of $91.06. The stock has a market cap of $42.53 billion, a PE ratio of 159.04, a P/E/G ratio of 2.15 and a beta of 0.74. The business has a 50 day moving average of $85.05 and a 200-day moving average of $81.25. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the firm earned $0.84 EPS. The company’s revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, equities research analysts forecast that Ventas, Inc. will post 3.86 earnings per share for the current year.

Ventas Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Tuesday, June 30th. Ventas’s payout ratio is 378.18%.

Institutional Investors Weigh In On Ventas

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Dynamic Wealth Strategies LLC bought a new stake in Ventas during the first quarter worth $25,000. GoalVest Advisory LLC bought a new stake in Ventas during the fourth quarter worth $26,000. Cloud Capital Management LLC bought a new stake in Ventas during the third quarter worth $25,000. Wiser Advisor Group LLC bought a new stake in Ventas during the third quarter worth $27,000. Finally, IFC & Insurance Marketing Inc. bought a new stake in Ventas during the fourth quarter worth $30,000. 94.18% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $93.00 price target on shares of Ventas in a research note on Monday, February 9th. Royal Bank Of Canada boosted their price target on Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Citigroup boosted their price target on Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a research note on Friday, May 1st. Morgan Stanley set a $90.00 price target on Ventas in a research note on Friday, February 13th. Finally, Argus set a $88.00 price target on Ventas in a research note on Tuesday, February 10th. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Ventas currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.00.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.